Summary:
- The article discusses the expected growth of the alopecia areata market during the forecast period of 2019-2032, according to a report by DelveInsight.
- Alopecia areata is an autoimmune condition that causes hair loss, and the article mentions key companies involved in the development of treatments for this condition, including Alcaris Therapeutics Inc.
- The article highlights the increasing prevalence of alopecia areata and the growing demand for effective treatments, which is expected to drive the growth of the market during the forecast period.